Siblings Patents [0/13] Periodical Articles [54/56] Collection Statistics Item counts issued in 3 years:4(20.00%) Items With Fulltext:17(85.00%) Download counts of the item Download times greater than 0:17(100.00%) Download times greater than 100:14(82.35%) Total Bitstream Download Counts:6432(21.71%) Last Update: 2025-04-20 11:04 Top Upload Loading... Top Download Loading... Recent Submissions Adverse effects of tyrosine kinase ... Mitochondrial phosphoenolpyruvate c... IGFBP3 promotes radiosensitivity of... Risk of type 2 diabetes mellitus an... Improved survival with neoadjuvant ... Phase 1 study of nanoliposomal irin... IGFBP3 promotes radiosensitivity of... The epidemiology of gastric cancer ... c-Myc promotes lymphatic metastasis... The role of aberrant mitochondrial ...

Jump to a point in the index: (Choose year) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (Choose month) January February March April May June July August September October November December Or type in a year:

Ordering With Most Recent First Show Oldest First

Showing items 1-10 of 20. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page

Date	Title	Relation
2024-11	Adverse effects of tyrosine kinase inhibitors on glucose and lipid metabolism in patients with chronic myeloid leukemia	Pharmacoepidemiology and Drug Safety. 2024 Nov;33:165-166.
2024-03	Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) promotes progression of triple negative breast cancer	Cancer Science. 2024 Mar;115(Suppl. 1):1536.
2024-03	IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NFkappaB/IL-6/ROS signaling	Cancer Science. 2024 Mar;115(Suppl. 1):1429.
2023-10	Risk of type 2 diabetes mellitus and hyperlipidemia in patients with chronic myeloid leukemia initiating tyrosine kinase inhibitors: A nationwide cohort study	Pharmacoepidemiology and Drug Safety. 2023 Oct;32(Suppl. S1):575.
2022-07	Improved survival with neoadjuvant chemotherapy in stage III pancreatic cancer: A single institutional experience	Annals of Oncology. 2022 Jul;33(Suppl. 6):S535.
2022-02	Phase 1 study of nanoliposomal irinotecan in combination with trifluridine/tipiracil in refractory solid tumors	Journal of Clinical Oncology. 2022 Feb;40(4, Suppl.):660.
2021-02	IGFBP3 promotes radiosensitivity of OSCC via appositive feedback of NF kappa B/IL-6/ROS signaling	Cancer Science. 2021 Feb;112(Suppl. 1):776.
2018-12	c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation	Cancer Science. 2018 Dec;109(Suppl. 2):866.
2018-12	The epidemiology of gastric cancer in the era of H. pylori eradication: A nation-wide registry-based study in Taiwan	Cancer Science. 2018 Dec;109(Suppl. 2):1437.
2018-01	The role of aberrant mitochondrial phosphoenolpyruvate carboxykinase expression in pancreatic neuroendocrine tumors	Cancer Science. 2018 Jan;109(Suppl. 1):466.

Showing items 1-10 of 20. (2 Page(s) Totally) 1 2 > >> View [10|25|50] records per page